1. Field of the Invention
This invention relates generally to the fields of biochemistry and medicine, and more specifically to compounds useful as cancer chemotherapeutic agents.
2. Background Information
Cancer is a leading cause of death in the United States. Despite significant efforts to find new approaches for treating cancer, surgery, chemotherapy and radiation therapy, either alone or in combination, remain the methods of choice. Surgery and radiation therapy, however, generally are useful only for fairly defined cancers and are of limited use for treating patients with disseminated disease.
Chemotherapy is the method of choice for treating patients with metastatic cancer or patients with diffuse cancers such as leukemia. Although chemotherapy can provide a therapeutic benefit in many cancer patients, it often fails to result in cure of the disease due to the patient's cancer cells becoming resistant to the chemotherapeutic agent. Due, in part, to the likelihood of cancer cells becoming resistant to a chemotherapeutic agent, these drugs commonly are used in combination to treat patients.
A continuing effort is being made by individual academic investigators, and by large and small pharmaceutical companies to identify new and useful chemotherapeutic agents. Various drug/agent strategies have been developed. In some instances, derivatives of known effective drugs are prepared and examined for improved or different, but useful characteristics. Another approach is to develop or acquire large libraries of randomly synthesized drugs candidates, and screen these compounds for potential efficacy as chemotherapeutic agents. Both of these methods have resulted in the identification of potentially useful agents. Yet another approach has been to identify potentially useful drugs that are produced naturally by living organisms. For example, paclitaxel is a compound that is produced by the yew tree and, when purified, is effective in treating cancers such as ovarian carcinoma.
Despite the identification of such new chemotherapeutic agents, there is still an unmet need for additional compounds that can be used to treat diseases such as cancer. The present invention addresses this need, as well as provides for additional advantages.
USPTO Backgrounds
USPTO Backgrounds